Pablo Arroyo-Pereiro

7PUBLICATIONS
17CO-AUTHORS
Central nervous systemMedical bacteriologyTō te Māori mātauranga hangarau, mātauranga atu anō, mātauranga haere tonu, me te mātauranga hapori (Māori technical, further, continuing and community education)Speech pathologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 22, 2026
Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

|Nov 05, 2025
Benign multiple sclerosis and long-term outcomes after 30 years.

E Matas, L Bau, L Romero-Pinel

|Oct 03, 2025
3D T1 turbo spin echo improves detection of gadolinium-enhancing multiple-sclerosis lesions.

Pablo Naval-Baudin, William F Bermúdez Bravo, Vanessa I Pineda-Borja

|Sep 16, 2024
Assessment of the Multiple Sclerosis Severity Score and the Age-Related Multiple Sclerosis Severity Score as health indicators in a population-based cohort.

Laura Bau, Elisabet Matas, Lucía Romero-Pinel

|Mar 13, 2023
Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experiment.

Albert Muñoz-Vendrell, Pablo Arroyo-Pereiro, Isabel León

Pageof 2

Frequent Collaborators

5 joint publications

Lucía Romero-Pinel

5 joint publications

Antonio Martínez-Yélamos

5 joint publications

Sergio Martínez-Yélamos

4 joint publications

Albert Muñoz-Vendrell